muscle weakness_Aspa<tm1a(EUCOMM)Wtsi>/Aspa<tm1a(EUCOMM)Wtsi>

http://metadb.riken.jp/0000747IC57BL6JC57BL6NAspatm1aEUCOMMWtsiAspatm1aEUCOMMWtsiAspatm1aEUCOMMWtsi

muscle weakness_Aspa<tm1a(EUCOMM)Wtsi>/Aspa<tm1a(EUCOMM)Wtsi>

表現型アノテーション

MGI marker

http://metadb.riken.jp/db/mgi_rdf/variant_of

• aspartoacylase
  http://metadb.riken.jp/db/mgi_rdf/MGI:87914

遺伝子型

http://metadb.riken.jp/db/mgi_rdf/allele_composition

• Aspa<tm1a(EUCOMM)Wtsi>/Aspa<tm1a(EUCOMM)Wtsi>

アレルシンボル

http://metadb.riken.jp/db/mgi_rdf/allele_symbol

• Aspa<tm1a(EUCOMM)Wtsi>

遺伝的背景

http://metadb.riken.jp/db/mgi_rdf/genetic_background

• involves: C57BL/6J * C57BL/6N

MP annotation

http://metadb.riken.jp/db/bioresource_schema/brs_indicatesPhenotype

• muscle weakness
  http://purl.obolibrary.org/obo/MP_0000747

文献

http://purl.org/net/cito/citesAsAuthority

• Nadine. Mersmann, et.al., Aspartoacylase-lacZ knockin mice: an engineered model of Canavan disease., PloS one, 2011, 6
  http://rdf.ncbi.nlm.nih.gov/pubmed/21625469